Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $913.10 | 38 | 93.3% |
| Gift | $59.40 | 1 | 6.1% |
| Education | $6.02 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $337.28 | 13 | $0 (2020) |
| Novo Nordisk Inc | $265.32 | 14 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $150.38 | 3 | $0 (2017) |
| Mannkind Corporation | $75.96 | 2 | $0 (2019) |
| AbbVie, Inc. | $57.30 | 3 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $52.69 | 3 | $0 (2017) |
| Corcept Therapeutics | $19.96 | 1 | $0 (2019) |
| Gemini Laboratories, LLC | $19.63 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $63.49 | 3 | SANOFI-AVENTIS U.S. LLC ($63.49) |
| 2019 | $178.29 | 7 | Mannkind Corporation ($75.96) |
| 2018 | $313.61 | 12 | SANOFI-AVENTIS U.S. LLC ($186.11) |
| 2017 | $423.13 | 18 | Janssen Pharmaceuticals, Inc ($150.38) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Endocrinology | ||||||
| 08/12/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Endocrinology | ||||||
| 06/03/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Endocrinology | ||||||
| 11/13/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Diabetes | ||||||
| 10/09/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: DIABETES | ||||||
| 08/28/2019 | Mannkind Corporation | AFREZZA (Drug) | Gift | In-kind items and services | $59.40 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/28/2019 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/21/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: DIABETES | ||||||
| 06/12/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: DIABETES | ||||||
| 05/08/2019 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Endocrinology | ||||||
| 10/25/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: DIABETES | ||||||
| 09/27/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: DIABETES | ||||||
| 09/12/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: DIABETES | ||||||
| 09/05/2018 | Gemini Laboratories, LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/12/2018 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug), FIASP | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Diabetes | ||||||
| 06/20/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Diabetes | ||||||
| 06/20/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: DIABETES | ||||||
| 05/10/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $119.90 | General |
| Category: DIABETES | ||||||
| 04/04/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Diabetes | ||||||
| 03/08/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Diabetes | ||||||
| 02/21/2018 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Diabetes | ||||||
| 02/06/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: DIABETES | ||||||
| 12/06/2017 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Endocrinology | ||||||
| 11/08/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Diabetes | ||||||
| 10/11/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 4 | 183 | 357 | $29,688 | $11,717 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 78 | 171 | $23,598 | $10,207 | 43.3% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 39 | 60 | $4,200 | $577.09 | 13.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 13 | $700.00 | $492.46 | 70.4% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 53 | 113 | $1,190 | $440.41 | 37.0% |
About Dr. Daniel Corredor, MD
Dr. Daniel Corredor, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Stafford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003906512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Corredor, MD has received a total of $978.52 in payments from pharmaceutical and medical device companies, with $63.49 received in 2020. These payments were reported across 40 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($913.10).
As a Medicare-enrolled provider, Corredor has provided services to 183 Medicare beneficiaries, totaling 357 services with total Medicare billing of $11,717. Data is available for 1 year (2020–2020), covering 4 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Stafford, TX
- Active Since 10/13/2006
- Last Updated 09/26/2016
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003906512
Products in Payments
- TOUJEO (Drug) $183.12
- INVOKANA (Drug) $150.38
- Ozempic (Drug) $86.85
- AFREZZA (Drug) $75.96
- Victoza (Drug) $74.85
- SOLIQUA 100/33 (Biological) $63.49
- Synthroid (Drug) $57.30
- FARXIGA (Drug) $52.69
- SOLIQUA (Drug) $49.26
- SOLIQUA 100/33 (Drug) $41.41
- Xultophy 100/3.6 (Drug) $39.42
- Korlym (Drug) $19.96
- UNITHROID (Drug) $19.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.